LONDON, May 5, 2014 /PRNewswire/ --
The markets on Friday, May 02, 2014 ended on a lower note as the Dow Jones Industrial Average finished the day at 16,512.89, down 0.28%, and the NASDAQ Composite closed at 4,123.90, down 0.09%. The S&P 500 finished the session 0.13% lower at 1,881.14. The losses were broad based as six out of ten sectors finished negative. Investor-Edge looks at some of the equities that hit a new 52-week high during the last session. These include AerCap Holdings N.V. (NYSE: AER), Impax Laboratories Inc. (NASDAQ: IPXL), FelCor Lodging Trust Inc. (NYSE: FCH) and Novartis AG (NYSE: NVS). Free technical research on AER, IPXL, FCH and NVS can be downloaded upon signing up at: http://www.investor-edge.com/2088-register Shares in AerCap Holdings N.V. advanced 2.53% on Friday, finishing the day at $43.83, hitting a new 52-week high of $44.07. The stock recorded a trading volume of 2.08 million shares, above to its three months average volume of 1.04 million shares. The stock fluctuated between $42.67 and $44.07 during the trading session. Over the last one month and previous three months, AerCap Holdings N.V.'s shares have gained 7.53% and 13.67%, respectively. Additionally, the stock has advanced 14.29% since the start of this year. The S&P 500 Industrials Sector Index mapped a loss of 0.08% during the session, and the index has advanced 7.86% in the last three months. The stock is trading above its 50-day and 200-day moving averages. Additionally, AerCap Holdings N.V.'s 50-day moving average of $41.01 is above its 200-day moving average of $28.86. Additionally, the stock has a Relative Strength Index (RSI) of 67.81. Sign up today to read free research on AER at: http://www.investor-edge.com/2088-AER-05May2014.pdf On Friday, Impax Laboratories Inc.'s stock oscillated between $26.66 and $29.46, hitting a new 52-week high of $29.46.The company closed the day 1.62% higher at $27.00. The company's stock reported a trading volume of 1.86 million shares, above its three months average volume of 0.75 million shares. Shares of the company traded at a PE ratio of 37.07. Impax Laboratories Inc.'s shares have surged 14.41% in the last one month, 19.68% in the previous three months and 7.40% on YTD basis. The S&P 500 Health Care Sector Index registered a loss of 0.77% during the session, while the index has gained 4.97% in the previous three months. Impax Laboratories Inc.'s stock is trading above its 50-day and 200-day moving averages of $25.95 and $23.07, respectively. Further, shares of the company have a RSI of 60.43. Sign up today to read free research on IPXL at: http://www.investor-edge.com/2088-IPXL-05May2014.pdf Shares in FelCor Lodging Trust Inc. ended the day at $9.59, up 3.23%, hitting a new 52-week high of $9.79. A total of 1.36 million shares were traded, which was above its three months average volume of 0.80 million shares. The stock moved between $9.29 and $9.79 during the session. Over the last one month and the previous three months, FelCor Lodging Trust Inc.'s shares have surged 5.38% and 21.55%, respectively. Moreover, since the beginning of the year, the company's stock has gained an upside of 17.52%. The S&P 500 Financials Sector Index ended flat, during the session, and the index has gained 6.22% in the previous three months. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $9.01 is greater than its 200-day moving average of $7.42. FelCor Lodging Trust Inc.'s stock has an RSI of 64.20. Sign up today to read free research on FCH at: http://www.investor-edge.com/2088-FCH-05May2014.pdf On Friday, Novartis AG's stock edged 0.41% higher, finishing the day at $87.36, after hitting a new 52-week high of $87.75. The stock recorded a trading volume of 1.30 million shares, lower than its three month average volume of 1.81 million shares. Novartis AG's shares have advanced 5.88% in the last one month, 11.71% in the previous three months and 8.68% on YTD basis. The S&P 500 Health Care Sector Index reported a loss of 0.77% during the session, while the index has advanced 4.97% in the last three months. Novartis AG's stock is trading above its 50-day and 200-day moving averages of $83.49 and $78.67, respectively. Furthermore, shares of the company have an RSI of 65.89. Sign up today to read free research on NVS at: http://www.investor-edge.com/2088-NVS-05May2014.pdf =============== EDITOR'S NOTES: =============== 1. This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com. 5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com. 6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.